ISL – January 2021 Page 141 of 160 EQAS  Evaluation  Result  Penalty Points  Steroid Profile Markers  |z-score| ≥ 3.0  (Occurrences*)  |z-score| ≥ 3.0 and CAR   4-7 Unsatisfactory CAR 2 Satisfactory and timely CAR 1 8-12 Unsatisfactory CAR 4 Satisfactory and timely CAR 2 13-18 Unsatisfactory CAR 6 Satisfactory and timely CAR 3 ≥ 19 Unsatisfactory CAR 8 Satisfactory and timely CAR 4 GC/C/IRMS δ13C (≥ 3 Occurrences**)   Threshold Substances  (per occurrence)  2.0 < |z -score| < 3.0  Internal Investigation  0 |z-score| ≥ 3.0 31 Unsatisfactory CAR 5 |z-score| ≥ 3.0 31 Satisfactory and timely CAR 0 SG determination  (per occurrence)  |z-score| ≥ 3.0   Unsatisfactory CAR 1 Documentation*** or Technical Issue  (per occurrence)  ISL, TD or TL Nonconformity  2 Unsatisfactory CAR 2 Late Submission of CAR   (per 7 days beyond the deadline) 1 Late reporting of blind or double -blind EQAS  results  32   (late reporting 8 to 14  days beyond the deadline)  2 2 Evaluation  Penalty Points  Sanction  Point Total for single EQAS  round (blind or double -blind****)  ≥ 20  Suspension   Or  Analytical Testing  Restriction   Point Total for double -blind EQAS **** for 12 -month period  23 Point Total for routine Analytical Testing **** for 12 -month period  23 Point Total (blind and double -blind EQAS  and routine Analytical Testing )****  for 12-month period  23 ≥ 30 * Based on a total of 6 determinations: Androsterone (A), Etiocholanolone (Etio), Testosterone (T), Epitestosterone (E), 5 -androstane -3,17β-diol (5Adiol) and 5β -androstane -3,17β-diol (5βAdiol ) per EQAS  sample.